See the latest coronavirus and vaccine informationLearn about the Lancaster General Hospital Emergency Department expansion and related traffic changes.

LG Health experts will speak at “Complex Pain Management Part 2: Developing Referral Pathways,” Wednesday evening, Oct. 12, at Ann B. Barshinger Cancer Institute.
Participants will learn how long-term use of benzodiazepines (benzos) is ultimately detrimental to the treatment of anxiety, and to instead consider behavioral therapy in addition to non-addictive medications. They also will learn that weaning from benzos is a long-term and often painful process, and to anticipate patient anxiety as a consequence of withdrawal.
LGHP Director of Clinical Affairs Dr. Paul Conslato will give introductory remarks and updates on LGHP’s chronic opioid therapy program and the Pennsylvania Prescription Drug Monitoring Program.
Joseph A. Troncale, M.D., Medical Director, Retreat at Lancaster County, and Alice Yoder, RN, LG Health Director of Community Health, will speak on “Developing a Referral Pathway.”
The program also will include a patient story and case studies on benzo weaning with Terrence Jones, M.D., Family Medicine Manheim, and fentanyl weaning with Celeste Heckman, M.D., of Family Medicine Strasburg. 
The event will conclude with Q&A with panel members Dr. Troncale; Christa Coleman, PsyD, LGHP Neuropsychology; Adam Lake, M.D., Family Medicine Downtown; and Madhavi Reddy, M.D., Anesthesia Associates of Lancaster.
Dinner will begin at 5 p.m., followed by the program, 5:30 to 7:15 p.m. To register, visit and click on Register for Live Event.

Share This Page: